Levosert

Levonorgestrel, the active ingredient in Levosert, is a progestin presented as an intrauterine system for intrauterine use. It provides long‑acting reversible contraception for women of reproductive age. GNH USA supplies Levosert as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levosert, a levonorgestrel‑releasing intrauterine system, is used within the hormonal contraceptive pathway for long‑acting reversible contraception.

Contraception: provides effective prevention of pregnancy for up to five years. Menstrual regulation: reduces menstrual blood loss and can improve cycle regularity. Endometrial protection: suppresses endometrial proliferation during use.

Levosert may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Irregular bleeding or spotting - Amenorrhea (absence of periods) - Cramping or pelvic pain - Headache - Breast tenderness - Nausea

Serious or Rare Side Effects: - Uterine perforation during insertion - Pelvic inflammatory disease - Ectopic pregnancy if contraception fails - Device expulsion - Severe allergic reaction - Hormone‑related thromboembolic events

Before using Levosert, certain precautions should be observed to ensure safety and effectiveness.

Screen for pregnancy: confirm the patient is not pregnant prior to insertion. Assess uterine anatomy: evaluate for fibroids, septa, or other abnormalities. Monitor for infection: advise patients to report fever, unusual discharge, or pelvic pain. Avoid in active pelvic infection: postpone insertion until infection resolves. Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Levosert can interact with other medicines that affect hormone metabolism or uterine environment.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampin): may reduce levonorgestrel efficacy. - Anticonvulsants (e.g., carbamazepine): may lower hormone levels and increase failure risk.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline): possible slight reduction in contraceptive effect. - Antifungal agents (e.g., ketoconazole): may increase levonorgestrel concentrations. - Herbal supplements (e.g., St. John’s wort): may decrease hormonal effectiveness.